JAK Inhibitor in Acquired Hemophagocytic synDrome in the Intensive Care Unit

Conditions: Hemophagocytic Syndromes Interventions: Drug: Ruxolitinib Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials